COMBINATION THERAPY FOR HIV INFECTION

(19)

(11)

EP 0 767 664 A2

(12)

(43)	Date of publication:
	16.04.1997 Bulletin 1997/16

(21)	Application number: 95923935.0

(22)	Date of filing: 23.06.1995

(51)

International Patent Classification (IPC):

A61K^{( . )}
A61K 31/ 495^{( . )}
A61K 31/ 55^{( . )}
A61P 31/ 12^{( . )}
A61P 43/ 00^{( . )}

C07H^{( . )}
A61K 31/ 165^{( . )}
A61K 31/ 70^{( . )}
A61P 37/ 04^{( . )}

(86)	International application number:
	PCT/US1995/007690

(87)	International publication number:
	WO 1996/000068 (04.01.1996 Gazette 1996/02)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

27.06.1994 US 19940267085

(71)	Applicant: Merck & Co., Inc.
	Rahway New Jersey 07065-0900 (US)

(72)	Inventors:
	EMINI, Emilio A. Rahway, NJ 07065 (US) HUFF, Joel R. Rahway, NJ 07065 (US)

(74)	Representative: Cole, William Gwyn, et al
	European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow Essex CM20 2QR Harlow Essex CM20 2QR (GB)

(54)	COMBINATION THERAPY FOR HIV INFECTION